Search results
RHHBY vs. ABBV: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance· 1 year agoInvestors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard...
NVS vs. RHHBY: Which Stock Should Value Investors Buy Now?
Zacks via Yahoo Finance· 2 years agoInvestors interested in Large Cap Pharmaceuticals stocks are likely familiar with Novartis (NVS) and...
Roche's (RHHBY) Late-Stage Lung Cancer Study Meets Primary Goal
Zacks via Yahoo Finance· 10 months agoRoche Holding AG RHHBY announced that the late-stage study evaluating Alecensa (alectinib) met its...
Roche (RHHBY) & Lilly to Co-Develop Alzheimer's Detection Device
Zacks via Yahoo Finance· 1 year agoRoche Holding AG RHHBY announced a collaboration with Eli Lilly and Company LLY where the latter...
Amgen (AMGN) Beats on Q3 Earnings & Sales, Tweaks 2022 View
Zacks via Yahoo Finance· 2 years agoAmgen AMGN reported third-quarter 2022 earnings of $4.70 per share, which beat the Zacks Consensus...
Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study
Zacks via Yahoo Finance· 2 months agoRoche Holding AG RHHBY announced that the late-stage study evaluating its marketed drug, Columvi...
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
Zacks via Yahoo Finance· 10 months agoRoche's (RHHBY) stock jumps 4.3% on Wednesday after the company inadvertently publishes encouraging...
Roche's (RHHBY) Lunsumio Gets FDA Nod for Follicular Lymphoma
Zacks via Yahoo Finance· 2 years agoRoche RHHBY announced that the FDA approved intravenously-administered Lunsumio (mosunetuzumab) for...
Roche's (RHHBY) Hemophilia A Drug Gets Positive CHMP Opinion
Zacks via Yahoo Finance· 2 years agoRoche RHHBY announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
Prothena (PRTA) Q2 Earnings Miss, Pipeline Progress in Focus
Zacks via Yahoo Finance· 2 years agoClinical-stage company Prothena Corporation PRTA reported second-quarter 2022 loss of 88 cents per...